292 related articles for article (PubMed ID: 29845812)
1. [Bioresorbable Vascular Scaffold: A Focused Review on Development and Preclinical Studies].
Ke L; Huang Y; Liu L; Duan X; Feng X; Wang C
Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Feb; 42(2):115-118. PubMed ID: 29845812
[TBL] [Abstract][Full Text] [Related]
2. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.
Rizik DG; Hermiller JB; Kereiakes DJ
Catheter Cardiovasc Interv; 2016 Nov; 88(S1):21-30. PubMed ID: 27797464
[TBL] [Abstract][Full Text] [Related]
3. A review of bioresorbable scaffolds: hype or hope?
Tan HC; Ananthakrishna R
Singapore Med J; 2017 Sep; 58(9):512-515. PubMed ID: 27868135
[TBL] [Abstract][Full Text] [Related]
4. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
Puricel S; Arroyo D; Corpataux N; Baeriswyl G; Lehmann S; Kallinikou Z; Muller O; Allard L; Stauffer JC; Togni M; Goy JJ; Cook S
J Am Coll Cardiol; 2015 Mar; 65(8):791-801. PubMed ID: 25720622
[TBL] [Abstract][Full Text] [Related]
5. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).
Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Scalone G; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):189-197. PubMed ID: 25616924
[TBL] [Abstract][Full Text] [Related]
6. A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions.
Jabbour RJ; Ielasi A; Tanaka A; Leoncini M; Cortese B; Grigis G; Mitomo S; Regazzoli D; Di Palma G; Rapetto C; Tespili M; Colombo A; Latib A
Cardiovasc Revasc Med; 2017; 18(5S1):S4-S9. PubMed ID: 28314675
[TBL] [Abstract][Full Text] [Related]
7. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: what have we learned from randomized-controlled clinical trials?
Rizik DG; Hermiller JB; Simonton CA; Klassen KJ; Kereiakes DJ
Coron Artery Dis; 2017 Jan; 28(1):77-89. PubMed ID: 27561169
[TBL] [Abstract][Full Text] [Related]
8. Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives.
Kitabata H; Waksman R; Warnack B
Cardiovasc Revasc Med; 2014 Mar; 15(2):109-16. PubMed ID: 24684760
[TBL] [Abstract][Full Text] [Related]
9. Current status of bioresorbable scaffolds in the treatment of coronary artery disease.
Wiebe J; Nef HM; Hamm CW
J Am Coll Cardiol; 2014 Dec; 64(23):2541-51. PubMed ID: 25500240
[TBL] [Abstract][Full Text] [Related]
10. [Research Progress of Bioresorbable Scaffold].
Liu Q; Cui S; Zhao Q; Chen M; Zheng B; Huo Y
Zhongguo Yi Liao Qi Xie Za Zhi; 2017 Sep; 41(5):357-361. PubMed ID: 29862725
[TBL] [Abstract][Full Text] [Related]
11. [Hybrid percutaneous coronary intervention with drug-eluting stent in combination with bioresorbable vascular scaffolds for complex coronary lesions].
Fineschi M; Carrera A; Pierli C
G Ital Cardiol (Rome); 2017 Sep; 18(9 Suppl 1):21S-23S. PubMed ID: 28845861
[TBL] [Abstract][Full Text] [Related]
12. Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS-DES percutaneous coronary intervention: Method and rationale for hybrid overlapping PCI.
Yew KL
Int J Cardiol; 2015; 186():74-6. PubMed ID: 25814348
[No Abstract] [Full Text] [Related]
13. The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment.
Gil RJ; Bil J; Pawłowski T; Yuldashev N; Kołakowski L; Jańczak J; Jabłoński W; Paliński P
Kardiol Pol; 2016; 74(7):627-33. PubMed ID: 26779846
[TBL] [Abstract][Full Text] [Related]
14. Bioresorbable vascular scaffolds: design, clinical trials, and current applications.
Devito F; Zito A; Dachille A; Carbonara R; Giardinelli F; Bulzis G; Navarese EP; Scicchitano P; Gaglione A; Masi F; Ciccone MM
Coron Artery Dis; 2016 Mar; 27(2):151-8. PubMed ID: 26717005
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: design of and rationale for the ABSORB III randomized trial.
Kereiakes DJ; Ellis SG; Popma JJ; Fitzgerald PJ; Samady H; Jones-McMeans J; Zhang Z; Cheong WF; Su X; Ben-Yehuda O; Stone GW
Am Heart J; 2015 Oct; 170(4):641-651.e3. PubMed ID: 26386787
[TBL] [Abstract][Full Text] [Related]
16. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial.
Arroyo D; Gendre G; Schukraft S; Kallinikou Z; Müller O; Baeriswyl G; Stauffer JC; Goy JJ; Togni M; Cook S; Puricel S
Int J Cardiol; 2017 Sep; 243():121-125. PubMed ID: 28576627
[TBL] [Abstract][Full Text] [Related]
17. Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial.
Gao R; Yang Y; Han Y; Huo Y; Chen J; Yu B; Su X; Li L; Kuo HC; Ying SW; Cheong WF; Zhang Y; Su X; Xu B; Popma JJ; Stone GW;
J Am Coll Cardiol; 2015 Dec; 66(21):2298-2309. PubMed ID: 26471805
[TBL] [Abstract][Full Text] [Related]
18. Planned use of GP IIb/IIIa inhibitors is safe and effective during implantation of the Absorb Bioresorbable Vascular Scaffold.
Jessup DB; Grove MM; Marks S; Kirby A
Cardiovasc Revasc Med; 2018 Dec; 19(8):956-959. PubMed ID: 30097189
[TBL] [Abstract][Full Text] [Related]
19. Coronary Bioresorbable Vascular Scaffold Use in the Treatment of Coronary Artery Disease.
Testa L; Latib A; Montone RA; Colombo A; Bedogni F
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412870
[TBL] [Abstract][Full Text] [Related]
20. Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.
Tanaka A; Jabbour RJ; Latib A; Colombo A
Catheter Cardiovasc Interv; 2016 Nov; 88(S1):10-20. PubMed ID: 27797460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
